Rheumatic heart disease (RHD) claims hundreds of thousands of lives each year but diagnosis is difficult in poor countries. Now, researchers from Israel’s Ben-Gurion University have engineered a synthetic, antibody-free diagnostic probe that detects cardiac inflammatory biomarkers in blood.
https://www.bgu.ac.il/en/news-and-articles/low-cost-blood-probe-targets-rheumatic-heart-disease/